Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

As the most important viral cause of severe respiratory disease in infants and increasing recognition as important in the elderly and immunocompromised, respiratory syncytial virus (RSV) is responsible for a massive health burden worldwide. Prophylactic antibodies were successfully developed against...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Influenza Other Respir Viruses
Egile Nagusiak: Broadbent, Lindsay, Groves, Helen, Shields, Michael D, Power, Ultan F
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2015
Gaiak:
Expert Commentary
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474493/
https://ncbi.nlm.nih.gov/pubmed/25847510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12313
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak